VyLibra 28 Day Pack

RxCUI: 1994758
RxNorm name: VyLibra 28 Day Pack
Display name: VyLibra 28 Day Pack
Full name: VyLibra 28 Day Pack
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VyLibra	NORGESTIMATE AND ETHINYL ESTRADIOL	Afaxys Pharma, LLC	13bdc226-ecf8-4fd7-aa0e-ec19b6b74fc3	2025-01-04	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1994758

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
13bdc226-ecf8-4fd7-aa0e-ec19b6b74fc3	{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [VyLibra 28 Day] [BPCK] · VyLibra 28 Day Pack [PSN] · VyLibra 28 Day Pack [SY]	3	8	These highlights do not include all the information needed to use VyLibra safely and effectively. See full prescribing information for VyLibra. VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989	20250104
e5b71df3-d99e-4e2d-a0cf-4c2790a6907d	{21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [VyLibra 28 Day] [BPCK] · VyLibra 28 Day Pack [PSN] · VyLibra 28 Day Pack [SY]	3	3	These highlights do not include all the information needed to use VyLibra safely and effectively. See full prescribing information for VyLibra. VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989	20230607